CTN Bulletin logo
July 19, 2016   

FNA Node CTP Aspire Health Partners is #OrlandoStrong



Aspire LogoOn June 12, 2016, 49 people were murdered and 53 wounded at Pulse nightclub in Orlando.

The day of the incident and in the following days, CTN Florida Node Alliance Community Treatment Provider (CTP) Aspire Health Partners worked with other leaders in the community to organize a rapid response to emerging mental health needs.

Aspire counselors accompanied law enforcement in notifying next of kin. They provided support and counseling at the temporary crisis centers established at a Hampton Inn, the Beardall Community Center, and the Family Assistance Center (FAC) at the Citrus Bowl/Camping World. These were places where family and friends of Pulse patrons could go to learn if their loved ones had died or were in the hospital. Aspire counselors were also available at local vigils for people who needed support and, potentially, referrals for more services. Staff at Aspire’s Zebra Coalition established a crisis line to serve as the contact point for the LGBT Center that serves the community.

When the temporary facilities, including FAC, closed, Aspire continued to send out a Mobile Crisis Team to provide services to the survivors and family members of the tragedy. This team continues to be on call 24 hours per day and provides mental health assessment and intervention. The Mobile Crisis team only serves survivors and families at this time. However, other resources are available.

Aspire’s Zebra Coalition continues to staff and manage volunteers for the crisis line, which serves anyone in the community who was affected, even indirectly, by the tragedy. Zebra has long been a trusted provider of specialized services within Orlando’s LGBT community. Zebra has been open extended hours for drop ins and to support their clients.

Aspire has been providing counseling, outpatient medication services, care coordination and inpatient treatment to any survivor or family member who is seeking our services. Co-pays are waived, if the individual is insured, and services are provided at no charge to the individual, if the person is uninsured.

Pulse-affected clients are assessed for the potential of Acute Stress Syndrome and every effort is made to provide treatment to prevent the potential later development of Post Traumatic Stress Disorder (PTSD). In addition, training opportunities have been made available to Aspire staff to learn more about PTSD in preparation for the long term care that may be required for some members of the Central Florida community.

Aspire is privileged to have so many dedicated, talented and hardworking clinicians, physicians, and staff members who have worked long hours to provide services to people affected by this tragedy. Aspire is also privileged to be located in a community that stands strong.

CTN Trial Progress

Study results for Open Studies as of the July 18 trial Progress Report.

CTN-0050 - Long Term Follow-up to CTN-0027: Enrolled 877 (original N=1,267 START Study participants)

CTN-0051 - X-BOT (Extended Release Naltrexone vs. Buprenorphine for Opioid Treatment). Enrolled 570

CTN-0051-A2 - Detoxification TAU. Enrolled 10

CTN-0056-Ot - Testing and Linkage to HIV Care in China. Enrolled 478

CTN-0057-Ot - SBIRT-PC (SBIRT in Primary Care). Enrolled 108 (N=120)

CTN-0064 - Linkage to HCV Care. Enrolled 48

Total Enrolled in all Studies: 23,863

The CTN Library Wants Your CPDD Posters & Slides!

CPDD logoDid you present about the CTN at CPDD this year? We would love to include your poster or presentation in the Library! Email us at info@ctndisseminationlibrary.org and see what's already been submitted here.

· · · · · · · · · · · · · · · · · · · ·

Now Seeking Sites: New CTN Study, the PROUD Trial

X:BOTKatharine Bradley of the CTN Health Systems Node is leading a new study on the implementation of treatment for opioid use disorders in primary care. Initially, up to 20 health care systems will be screened for eventual selection into the study. All sites will be compensated for participating in the screening process.

The screening phase of PROUD (phase 1) will be held from fall 2016 through spring 2017. Sites for the PROUD trial, beginning in summer of 2017, will be selected during phase 1.

PROUD sites must be:

  • Health care systems with a single EHR that include multiple primary care sites;
  • Able to follow a large cohort of primary care patients with EHR data;
  • Able to obtain the following data on the primary care cohort: pharmacy data, health insurance claims for addictions treatment and ED/hospital care provided outside the health system, death data;
  • Willing to treat opioid use disorders in primary care.

Save the dates: The last two informational webinars will be held Wednesday, July 20th (register for: 9am Pacific webinar, 2pm Pacific webinar). The deadline for sites to indicate interest will be July 31. Those with access to the CTNDSC2.com website can read more about the PROUD trial here.

Read more. . .

· · · · · · · · · · · · · · · · · · · ·

News from the Nodes

The Northeast Node is pleased to co-sponsor the second annual New England ATTC conference on adolescent substance abuse treatment, “Improving Care of Adolescents with Substance Use Disorders: Effective Approaches to Assessing, Treating, and Engaging Teens” on Wednesday, July 20 at Dartmouth-Hitchcock Medical Center in Lebanon, NH.

The conference will enable participants to:

  • discuss prior research documenting the prevalence and consequences of untreated or ineffectively treated substance use disorders (SUDs) in adolescents;
  • choose appropriate screening tools and brief interventions to incorporate into their work with adolescents with or at risk of SUDs; and
  • apply at least one evidence-based approach to assessing, treating, or engaging adolescents with or at risk of SUDs.

Also, the next installment of the Northeast Node’s Science Series webinars will take place Thursday, July 21. Mark McGovern, PhD, will present “Why Strategies to Integrate Behavioral Health in Primary Care Are Unsuccessful and What Can Be Done About It?” More information, including registration information, the presentation description, and the presenter biography, can be found on the Node's Science Series webpage.


The Health Systems Node, based in Kaiser Permanente Northern California, is proud to announce Node Co-Investigator Cynthia Campbell, has the first publication in-press for the node.

The article is title "Prescription Opioid Registry Protocol in an Integrated Health System," and it'll be published in the American Journal of Managed Care (tentatively scheduled for the March 2017 issue). It's based on data from CTN-0061, the Kaiser Virtual Data Warehouse - Prescription Opioid Users study.

Congratulations to Dr. Campbell and her team!

News from the ATTC

The July 2016 ATTC Messenger's featured article is about "Improving Transitions from Detox to Continuing Care: The LINK Care Transition Implementation System."

There's also a new issue of The Bridge, a semi-annual e-pub that links science and service by providing information and tools on technology transfer and implementation science strategies. The Bridge is edited by Paul Roman, PhD, of the University of Georgia. Check it out here!

· · · · · · · · · · · · · · · · · · · ·

From the CTN Data & Statistics Center & Clinical Coordinating Center

CTN Clinical Trials Reports Website

We have officially launched the updated CTN website. The URL remains http://ctndsc2.com/. Users who had access to the previous website will have an account with the new website. To access your account for the first time, Request a New Password and supply the email used for previous website identification. Personal account information can be updated through the My Account tab.

Please note that the website has a Contact Us feature: this can be used for general questions as well as staff deactivations, protocol changes, and systems issues. The Research Staff Information Form is now also located on this website and can be completed and submitted online. Questions can also be directed to nidadsc2help@emmes.com.

National Drug Abuse Treatment Clinical Trials Toolbox

Have you seen the latest document in the Clinical Trials Network Investigator Toolbox? Don’t miss this informative guide on Study Close Out under the Implementation and Study Closeout section of the Toolbox: https://ctndsc2.com/system/files/StudyCloseout.pdf.

This document provides an overview of study and site close out procedures, and includes a sample Site Readiness for Closeout Checklist. For questions or comments, please contact Dee Blumberg at dblumberg@emmes.com.

· · · · · · · · · · · · · · · · · · · ·

New from the CTN Dissemination Library

CTN-0049 Primary Outcomes
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients with HIV Infection and Substance Use: A Randomized Trial. Metsch LR, et al. JAMA 2016;316(2):156-170. Read more. . .

CTN-0054 Primary Outcomes
Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. Mooney LJ, et al. J Addict Med 2016 (in press). Read more. . .



Predictors of 12-Step Attendance and Participation for Individuals with Stimulant Use Disorders. Hatch-Maillette MA, et al. J Subst Abuse Treat 2016;68:74-82. Read more. . .

Smoking Among Patients in Substance Use Disorders Treatment: Associations with Tobacco Advertising, Anti-Tobacco Messages, and Perceived Health Risks. Campbell BK, et al. Am J Drug Alcohol Abuse 2016 (in press). Read more. . .

Use of Multiple Tobacco Products in a National Sample of Persons Enrolled in Addiction Treatment. Guydish JR, et al. Drug Alcohol Depend 2016 (in press). Read more. . .

More New in the Library. . .

· · · · · · · · · · · · · · · · · · · ·

2016 Addiction Health Services Research Conference, October 13-15, 2016

The Alcohol & Drug Abuse Institute at the University of Washington (RRTC for the Pacific Northwest Node) and the Northwest Addiction Technology Transfer Center are pleased to host the 2016 AHSR conference in Seattle, Washington this October!

Early-bird registration is NOW OPEN (through Sept 1). You can also find out about mentoring opportunities on the conference website (be a mentor! get a mentor!), and check out the exciting line-up of plenary speakers.

Bookmark the conference website at http://ahsr2016.org for updates!

· · · · · · · · · · · · · · · · · · · ·

Also of Interest

Request for Information: Increasing the Varieties of Marijuana and Marijuana Products for Research (NOT-DA-16-034). NIDA is interested in gathering information from researchers conducting or interested in conducting research on marijuana and marijuana products. Read more about this ROI and find out how to respond here. The deadline is September 15, 2016.

Missed any of the Build Up Your Teen Treatment IQ Blending Initiative webinars? You can find recordings and slides online! Next webinar will be August 31st and will focus on The Value of Evidence Based Screening, Assessment, and Treatment for Adolescents with SUD.

Upcoming Meetings & Trainings

Pharmacotherapy Trials for Adolescent Substance Use Disorders: From Concept to Execution. CTN Webinar Series (free). August 10, 2016, 1-2p.m. ET. Register now!

9th Annual Conference on the Science of Dissemination and Implementation in Health. December 14-15, 2016. Abstract submission open until August 4! Read more. . .

For more upcoming meetings, trainings, and conferences, visit the CTN Dissemination Library's AOD Conferences calendar!